2. 医学
  3. Several classes of bitter citrus compound have looked promising as anticancer agents in laboratory tests. A new study indicates

Several classes of bitter citrus compound have looked promising as anticancer agents in laboratory tests. A new study indicates

admin2013-10-31  149
问题     Several classes of bitter citrus compound have looked promising as anticancer agents in laboratory tests. A new study indicates that long-term consumption of orange juice, a source of such chemicals cuts cancer risk in rats.
    In test-tube studies, one class of the bitter compounds—flavonoids—has inhibited the growth of breast cancer cells. Related studies showed that bitter citrus limonoids similarly ward off cancer in animals. Mulling over such data, Maurice R Bennink of Michigan State University in East Lansing wondered whether drinking orange juice would have a beneficial effect.
    His team injected 60 young rats with a chemical that causes colon cancer and then raised half of the animals on a normal diet. The others received orange juice instead of drinking water—and less sugar in their food to compensate for sugars in the juice.
    At an American Institute for Cancer Research meeting last week in Washington D. C. , Bennink reported that after 7 months, 22 of the animals receiving a normal diet had developed colon cancers. Only 17 of the rats on the orange-juice diet showed tumors. That’ s 77 percent of the control group’ s incidence.
    Concludes Bennink, whose work was supported by orange-juice producer Tropicana products of Brandenton, Fla. , " These data show orange juice helps protect against cancer. " He says that the study might also apply to breast, prostate, and lung cancers.
    Bandaru S. Reddy of the American Health Foundation in Valhalla, N. Y. , was not surprised by Bennink’ s finding of an orange juice benefit. However, he calls the reported risk reduction unimpressive. His own data show that citrus limonoids protect against chemically induced colon cancer in lab animals.
    Luke K. T. Lam of LKT Laboratories in St. Paul, Minn. , finds Bennink’ s data " quite interesting ," although he describes as " borderline" the suppression of cancer incidence observed by Bennink. Lam has inhibited tumors in the lung, skin and forestomach of mice with limonoinds.
The scientists don’ t know what compounds in orange juice underlie its effect. The juice is rich in one limonoid—a sugar-containing version of limonin, which suppressed tumors in Lam’ s experiments. It’ s possible, Lam speculates, that rats convert the juice’ s limonoid into limonin.
    Indeed, argues Gary D Manners of the Agricultural Research Service in Albany, Calif. , " there is no doubt that these [ anticancer ] citrus compounds are bioavailable in animals to the site of a cancer. The question remains whether they are similarly available in people". To find out, his team will soon begin measuring the human body’ s uptake of limonoids from orange juice.
It can be inferred from the passage that Bennink______.
选项 A、won much financial support with his unexpected results
B、had a commercial intention in the first place
C、tried to please orange-juice manufacturers
D、found a right sponsor
答案D
解析 第五段提到Bennink的研究是由orange-juice producer，Tropicana products of Brandenton支持的，故D项正确。其它三项文章均未提到，故排除。
转载请注明原文地址:https://kaotiyun.com/show/3BU3777K
本试题收录于： 医学博士外语题库考研分类
0

医学博士外语

考研

相关试题推荐
随机试题
最新回复(0)